Sage Journals: Discover world-class research

Abstract

Get full access to this article

View all access options for this article.

References

Feldstein

Rose

Horwitz

, et al. Multisystem inflammatory syndrome in U.S. children and adolescents. N Engl J Med. 2020;383(4):334-346. doi:10.1056/NEJMoa2021680.

Dufort

Koumans

Chow

, et al. Multisystem inflammatory syndrome in children in New York State. N Engl J Med. 2020;383(4):347-358. doi:10.1056/NEJMoa2021756.

Centers for Disease Control and Prevention. Information for healthcare providers about multisystem inflammatory syndrome in children (MIS-C). Date unknown. Accessed February 3, 2022. https://www.cdc.gov/mis/mis-c/hcp/index.html?CDC_AA_refVal=https%3A%2F%2Fwww.cdc.gov%2Fmis%2Fhcp%2Findex.html.

US Food & Drug Administration. FDA authorizes Pfizer-BioNTech COVID-19 vaccine for emergency use in children 5 through 11 years of age. Published 2021. Accessed February 3, 2022. https://www.fda.gov/news-events/press-announcements/fda-authorizes-pfizer-biontech-covid-19-vaccine-emergency-use-children-5-through-11-years-age.

Frenck

Jr Klein

Kitchin

, et al. Safety, immunogenicity, and efficacy of the BNT162b2 covid-19 vaccine in adolescents. N Engl J Med. 2021;385(3):239-250. doi:10.1056/NEJMoa2107456.

Walter

Talaat

Sabharwal

, et al. Evaluation of the BNT162b2 covid-19 vaccine in children 5 to 11 years of age. N Engl J Med. 2022;386(1):35-46. doi:10.1056/NEJMoa2116298.

Levy

Recher

Hubert

, et al. Multisystem inflammatory syndrome in children by COVID-19 vaccination status of adolescents in France. JAMA. 2022;327(3):281-283. doi:10.1001/jama.2021.23262.

Zambrano

Newhams

Olson

, et al. Effectiveness of BNT162b2 (Pfizer-BioNTech) mRNA vaccination against multisystem inflammatory syndrome in children among persons aged 12—18 years—United States, July-December 2021. MMWR Morb Mortal Wkly Rep. 2022;71(2):52-58. doi:10.15585/mmwr.mm7102e1.

Poussaint

LaRovere

Newburger

, et al. Multisystem inflammatory-like syndrome in a child following COVID-19 mRNA vaccination. Vaccines (Basel). 2021;10(1):43. doi:10.3390/vaccines10010043.

10.

Centers for Disease Control and Prevention. Health department-reported cases of multisystem inflammatory syndrome in children (MIS-C) in the United States. Date unknown. Accessed March 2, 2022. https://covid.cdc.gov/covid-data-tracker/#mis-national-surveillance.

11.

Centers for Disease Control and Prevention. CDC updates and shortens recommended isolation and quarantine period for the general population. Published 2021. Accessed March 2, 2022. https://www.cdc.gov/media/releases/2021/s1227-isolation-quarantine-guidance.html.

Is MIS-C (Multisystem Inflammatory Syndrome in Children) a Vaccine-Preventable Disease?

Abstract

Get full access to this article

References